位置:首页 > 蛋白库 > DVL2_MOUSE
DVL2_MOUSE
ID   DVL2_MOUSE              Reviewed;         736 AA.
AC   Q60838; Q7TN14;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 191.
DE   RecName: Full=Segment polarity protein dishevelled homolog DVL-2;
DE            Short=Dishevelled-2;
DE   AltName: Full=DSH homolog 2;
GN   Name=Dvl2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Brain;
RX   PubMed=8887313; DOI=10.1016/s0925-4773(96)00549-7;
RA   Klingensmith J., Yang Y., Axelrod J.D., Beier D.R., Perrimon N.,
RA   Sussman D.J.;
RT   "Conservation of dishevelled structure and function between flies and mice:
RT   isolation and characterization of Dvl2.";
RL   Mech. Dev. 58:15-26(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Amnion, and Kidney;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH DIXDC1 AND RAC.
RX   PubMed=15262978; DOI=10.1074/jbc.m404598200;
RA   Wong C.K., Luo W., Deng Y., Zou H., Ye Z., Lin S.-C.;
RT   "The DIX domain protein coiled-coil-DIX1 inhibits c-Jun N-terminal kinase
RT   activation by Axin and dishevelled through distinct mechanisms.";
RL   J. Biol. Chem. 279:39366-39373(2004).
RN   [7]
RP   INTERACTION WITH VANGL1 AND VANGL2.
RX   PubMed=15456783; DOI=10.1074/jbc.m408675200;
RA   Torban E., Wang H.-J., Groulx N., Gros P.;
RT   "Independent mutations in mouse Vangl2 that cause neural tube defects in
RT   looptail mice impair interaction with members of the Dishevelled family.";
RL   J. Biol. Chem. 279:52703-52713(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH THE AP-2 COMPLEX.
RX   PubMed=17199046; DOI=10.1016/j.devcel.2006.10.015;
RA   Yu A., Rual J.F., Tamai K., Harada Y., Vidal M., He X., Kirchhausen T.;
RT   "Association of Dishevelled with the clathrin AP-2 adaptor is required for
RT   Frizzled endocytosis and planar cell polarity signaling.";
RL   Dev. Cell 12:129-141(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10]
RP   FUNCTION, INTERACTION WITH DIXDC1, SUBUNIT, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF LYS-15; ILE-17; TYR-27; PHE-56; ASP-61; ASP-63; GLY-65;
RP   VAL-66 AND LYS-68, AND DOMAIN.
RX   PubMed=21189423; DOI=10.1074/jbc.m110.186742;
RA   Liu Y.T., Dan Q.J., Wang J., Feng Y., Chen L., Liang J., Li Q., Lin S.C.,
RA   Wang Z.X., Wu J.W.;
RT   "Molecular basis of Wnt activation via the DIX-domain protein Ccd1.";
RL   J. Biol. Chem. 286:8597-8608(2011).
RN   [11]
RP   INTERACTION WITH FAM105B.
RX   PubMed=23708998; DOI=10.1038/nature12296;
RA   Rivkin E., Almeida S.M., Ceccarelli D.F., Juang Y.C., Maclean T.A.,
RA   Srikumar T., Huang H., Dunham W.H., Fukumura R., Xie G., Gondo Y.,
RA   Raught B., Gingras A.C., Sicheri F., Cordes S.P.;
RT   "The linear ubiquitin-specific deubiquitinase gumby regulates
RT   angiogenesis.";
RL   Nature 498:318-324(2013).
RN   [12]
RP   INTERACTION WITH MAPK15.
RX   PubMed=25823377; DOI=10.1038/ncomms7666;
RA   Miyatake K., Kusakabe M., Takahashi C., Nishida E.;
RT   "ERK7 regulates ciliogenesis by phosphorylating the actin regulator CapZIP
RT   in cooperation with Dishevelled.";
RL   Nat. Commun. 6:6666-6666(2015).
RN   [13]
RP   INTERACTION WITH PKD1.
RX   PubMed=27214281; DOI=10.1038/ncb3363;
RA   Kim S., Nie H., Nesin V., Tran U., Outeda P., Bai C.X., Keeling J.,
RA   Maskey D., Watnick T., Wessely O., Tsiokas L.;
RT   "The polycystin complex mediates Wnt/Ca(2+) signalling.";
RL   Nat. Cell Biol. 18:752-764(2016).
RN   [14]
RP   INTERACTION WITH LMBR1L.
RX   PubMed=31073040; DOI=10.1126/science.aau0812;
RA   Choi J.H., Zhong X., McAlpine W., Liao T.C., Zhang D., Fang B., Russell J.,
RA   Ludwig S., Nair-Gill E., Zhang Z., Wang K.W., Misawa T., Zhan X., Choi M.,
RA   Wang T., Li X., Tang M., Sun Q., Yu L., Murray A.R., Moresco E.M.Y.,
RA   Beutler B.;
RT   "LMBR1L regulates lymphopoiesis through Wnt/beta-catenin signaling.";
RL   Science 364:0-0(2019).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 417-510 IN COMPLEX WITH AP2M1,
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=20947020; DOI=10.1016/j.str.2010.07.010;
RA   Yu A., Xing Y., Harrison S.C., Kirchhausen T.;
RT   "Structural analysis of the interaction between Dishevelled2 and clathrin
RT   AP-2 adaptor, a critical step in noncanonical Wnt signaling.";
RL   Structure 18:1311-1320(2010).
CC   -!- FUNCTION: Plays a role in the signal transduction pathways mediated by
CC       multiple Wnt genes. Participates both in canonical and non-canonical
CC       Wnt signaling by binding to the cytoplasmic C-terminus of frizzled
CC       family members and transducing the Wnt signal to down-stream effectors.
CC       Promotes internalization and degradation of frizzled proteins upon Wnt
CC       signaling. {ECO:0000269|PubMed:17199046, ECO:0000269|PubMed:20947020,
CC       ECO:0000269|PubMed:21189423}.
CC   -!- SUBUNIT: Interacts through its PDZ domain with the C-terminal regions
CC       of VANGL1 and VANGL2. Interacts with Rac. Interacts with ARRB1; the
CC       interaction is enhanced by phosphorylation of DVL1 (By similarity). Can
CC       form large oligomers (via DIX domain). Interacts (via DIX domain) with
CC       DIXDC1 (via DIX domain). Interacts (via DEP domain) with AP2M1 and the
CC       AP-2 complex. Interacts with FAM105B/otulin. Interacts with DCDC2.
CC       Interacts (when phosphorylated) with FOXK1 and FOXK2; the interaction
CC       induces DVL2 nuclear translocation (By similarity). Interacts with
CC       MAPK15 (PubMed:25823377). Interacts with PKD1 (via extracellular
CC       domain) (PubMed:27214281). Interacts with LMBR1L (PubMed:31073040).
CC       {ECO:0000250|UniProtKB:O14641, ECO:0000269|PubMed:15262978,
CC       ECO:0000269|PubMed:15456783, ECO:0000269|PubMed:17199046,
CC       ECO:0000269|PubMed:20947020, ECO:0000269|PubMed:21189423,
CC       ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:25823377,
CC       ECO:0000269|PubMed:27214281, ECO:0000269|PubMed:31073040}.
CC   -!- INTERACTION:
CC       Q60838; Q69ZU8-1: Ankrd6; NbExp=3; IntAct=EBI-641940, EBI-15605686;
CC       Q60838; Q8R4A3: Dact1; NbExp=3; IntAct=EBI-641940, EBI-3870250;
CC       Q60838; Q60838: Dvl2; NbExp=7; IntAct=EBI-641940, EBI-641940;
CC       Q60838; Q61062: Dvl3; NbExp=3; IntAct=EBI-641940, EBI-1538450;
CC       Q60838; Q80Z96: Vangl1; NbExp=4; IntAct=EBI-641940, EBI-1750708;
CC       Q60838; Q91ZD4: Vangl2; NbExp=4; IntAct=EBI-641940, EBI-1750744;
CC       Q60838; P84092: Ap2m1; Xeno; NbExp=4; IntAct=EBI-641940, EBI-297693;
CC       Q60838; P48730: CSNK1D; Xeno; NbExp=2; IntAct=EBI-641940, EBI-751621;
CC       Q60838; P49674: CSNK1E; Xeno; NbExp=3; IntAct=EBI-641940, EBI-749343;
CC       Q60838; Q9Y4D1-1: DAAM1; Xeno; NbExp=4; IntAct=EBI-641940, EBI-15677700;
CC       Q60838; Q155Q3: DIXDC1; Xeno; NbExp=4; IntAct=EBI-641940, EBI-1104700;
CC       Q60838; P53350: PLK1; Xeno; NbExp=12; IntAct=EBI-641940, EBI-476768;
CC       Q60838; Q9NZC7: WWOX; Xeno; NbExp=2; IntAct=EBI-641940, EBI-4320739;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17199046,
CC       ECO:0000269|PubMed:20947020}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:20947020}; Cytoplasmic side
CC       {ECO:0000269|PubMed:20947020}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:21189423}. Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:17199046, ECO:0000269|PubMed:21189423}. Nucleus
CC       {ECO:0000250|UniProtKB:O14641}. Note=Localizes at the cell membrane
CC       upon interaction with frizzled family members and promotes their
CC       internalization (PubMed:21189423). Localizes to cytoplasmic puncta.
CC       Interaction with FOXK1 and FOXK2 induces nuclear translocation (By
CC       similarity). {ECO:0000250|UniProtKB:O14641,
CC       ECO:0000269|PubMed:21189423}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The DIX domain mediates homooligomerization.
CC       {ECO:0000269|PubMed:21189423}.
CC   -!- PTM: Phosphorylated by CSNK1D (By similarity). WNT3A induces DVL2
CC       phosphorylation by CSNK1E and MARK kinases (By similarity).
CC       {ECO:0000250|UniProtKB:O14641}.
CC   -!- SIMILARITY: Belongs to the DSH family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U24160; AAC52827.1; -; mRNA.
DR   EMBL; AK146822; BAE27460.1; -; mRNA.
DR   EMBL; AK159895; BAE35461.1; -; mRNA.
DR   EMBL; AK168376; BAE40307.1; -; mRNA.
DR   EMBL; AL596185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466596; EDL12520.1; -; Genomic_DNA.
DR   EMBL; BC053050; AAH53050.1; -; mRNA.
DR   CCDS; CCDS24930.1; -.
DR   RefSeq; NP_031914.3; NM_007888.3.
DR   PDB; 3ML6; X-ray; 3.50 A; A/B/C/D/E/F=417-510.
DR   PDB; 6VCC; EM; 3.60 A; A/B/C/D/E/F/G/H/I/J/K/L=12-92.
DR   PDBsum; 3ML6; -.
DR   PDBsum; 6VCC; -.
DR   AlphaFoldDB; Q60838; -.
DR   BMRB; Q60838; -.
DR   SMR; Q60838; -.
DR   BioGRID; 199343; 23.
DR   CORUM; Q60838; -.
DR   DIP; DIP-29399N; -.
DR   IntAct; Q60838; 32.
DR   MINT; Q60838; -.
DR   STRING; 10090.ENSMUSP00000019362; -.
DR   iPTMnet; Q60838; -.
DR   PhosphoSitePlus; Q60838; -.
DR   EPD; Q60838; -.
DR   MaxQB; Q60838; -.
DR   PaxDb; Q60838; -.
DR   PRIDE; Q60838; -.
DR   ProteomicsDB; 277616; -.
DR   Antibodypedia; 3985; 502 antibodies from 39 providers.
DR   DNASU; 13543; -.
DR   Ensembl; ENSMUST00000019362; ENSMUSP00000019362; ENSMUSG00000020888.
DR   Ensembl; ENSMUST00000102575; ENSMUSP00000099635; ENSMUSG00000020888.
DR   Ensembl; ENSMUST00000190940; ENSMUSP00000140073; ENSMUSG00000020888.
DR   GeneID; 13543; -.
DR   KEGG; mmu:13543; -.
DR   UCSC; uc007jtm.1; mouse.
DR   CTD; 1856; -.
DR   MGI; MGI:106613; Dvl2.
DR   VEuPathDB; HostDB:ENSMUSG00000020888; -.
DR   eggNOG; KOG3571; Eukaryota.
DR   GeneTree; ENSGT00950000182903; -.
DR   HOGENOM; CLU_012601_1_0_1; -.
DR   InParanoid; Q60838; -.
DR   OMA; PAGAKYY; -.
DR   OrthoDB; 474724at2759; -.
DR   PhylomeDB; Q60838; -.
DR   TreeFam; TF318198; -.
DR   Reactome; R-MMU-201688; WNT mediated activation of DVL.
DR   Reactome; R-MMU-2028269; Signaling by Hippo.
DR   Reactome; R-MMU-4086400; PCP/CE pathway.
DR   Reactome; R-MMU-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-MMU-4641258; Degradation of DVL.
DR   Reactome; R-MMU-4641262; Disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; R-MMU-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-MMU-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-MMU-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-MMU-8856828; Clathrin-mediated endocytosis.
DR   BioGRID-ORCS; 13543; 0 hits in 57 CRISPR screens.
DR   ChiTaRS; Dvl2; mouse.
DR   PRO; PR:Q60838; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q60838; protein.
DR   Bgee; ENSMUSG00000020888; Expressed in embryonic brain and 155 other tissues.
DR   Genevisible; Q60838; MM.
DR   GO; GO:0016235; C:aggresome; ISO:MGI.
DR   GO; GO:0045177; C:apical part of cell; IDA:MGI.
DR   GO; GO:0005938; C:cell cortex; ISO:MGI.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:MGI.
DR   GO; GO:0005856; C:cytoskeleton; NAS:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:MGI.
DR   GO; GO:0016604; C:nuclear body; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005109; F:frizzled binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:MGI.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0043621; F:protein self-association; IDA:UniProtKB.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031267; F:small GTPase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IDA:MGI.
DR   GO; GO:0044340; P:canonical Wnt signaling pathway involved in regulation of cell proliferation; ISO:MGI.
DR   GO; GO:0090103; P:cochlea morphogenesis; IGI:MGI.
DR   GO; GO:0022007; P:convergent extension involved in neural plate elongation; IMP:MGI.
DR   GO; GO:0060029; P:convergent extension involved in organogenesis; IGI:MGI.
DR   GO; GO:0007507; P:heart development; IMP:MGI.
DR   GO; GO:0003007; P:heart morphogenesis; IGI:MGI.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0001843; P:neural tube closure; IMP:MGI.
DR   GO; GO:0035567; P:non-canonical Wnt signaling pathway; ISO:MGI.
DR   GO; GO:0003151; P:outflow tract morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0090179; P:planar cell polarity pathway involved in neural tube closure; IMP:MGI.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISO:MGI.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IDA:BHF-UCL.
DR   GO; GO:0150012; P:positive regulation of neuron projection arborization; IEA:Ensembl.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:MGI.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IGI:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0008104; P:protein localization; IDA:MGI.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISO:MGI.
DR   GO; GO:0007379; P:segment specification; IMP:MGI.
DR   GO; GO:0035282; P:segmentation; IGI:BHF-UCL.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IGI:MGI.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 2.40.240.130; -; 1.
DR   IDEAL; IID50127; -.
DR   InterPro; IPR000591; DEP_dom.
DR   InterPro; IPR024580; Dishevelled_C-dom.
DR   InterPro; IPR008339; Dishevelled_fam.
DR   InterPro; IPR003351; Dishevelled_protein_dom.
DR   InterPro; IPR001158; DIX.
DR   InterPro; IPR038207; DIX_dom_sf.
DR   InterPro; IPR015506; Dsh/Dvl-rel.
DR   InterPro; IPR008341; DVL2.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR10878; PTHR10878; 1.
DR   PANTHER; PTHR10878:SF8; PTHR10878:SF8; 1.
DR   Pfam; PF00610; DEP; 1.
DR   Pfam; PF02377; Dishevelled; 1.
DR   Pfam; PF00778; DIX; 1.
DR   Pfam; PF12316; Dsh_C; 1.
DR   Pfam; PF00595; PDZ; 1.
DR   PRINTS; PR01760; DISHEVELLED.
DR   PRINTS; PR01762; DISHEVELLED2.
DR   SMART; SM00021; DAX; 1.
DR   SMART; SM00049; DEP; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50186; DEP; 1.
DR   PROSITE; PS50841; DIX; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cytoplasm; Cytoplasmic vesicle;
KW   Developmental protein; Membrane; Nucleus; Phosphoprotein;
KW   Reference proteome; Wnt signaling pathway.
FT   CHAIN           1..736
FT                   /note="Segment polarity protein dishevelled homolog DVL-2"
FT                   /id="PRO_0000145747"
FT   DOMAIN          11..93
FT                   /note="DIX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00069"
FT   DOMAIN          267..339
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          433..507
FT                   /note="DEP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00066"
FT   REGION          93..255
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          558..665
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        107..123
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        147..174
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        575..599
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        602..616
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MUTAGEN         15
FT                   /note="K->A: Reduces oligomerization. Reduces activation of
FT                   Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         17
FT                   /note="I->A: Reduces oligomerization. Abolishes interaction
FT                   with DIXDC1. Reduces activation of Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         27
FT                   /note="Y->D: Loss of oligomerization. Abolishes interaction
FT                   with DIXDC1. Abolishes activation of Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         56
FT                   /note="F->H: Reduces oligomerization. Strongly reduced
FT                   activation of Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         61
FT                   /note="D->A: Reduces oligomerization. Reduces activation of
FT                   Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         63
FT                   /note="D->A: Reduces oligomerization. Reduces activation of
FT                   Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         64
FT                   /note="F->A: Reduces oligomerization. Reduces activation of
FT                   Wnt signaling."
FT   MUTAGEN         65
FT                   /note="G->D: Loss of oligomerization. Abolishes activation
FT                   of Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         66
FT                   /note="V->D: Reduces oligomerization. Reduces activation of
FT                   Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         68
FT                   /note="K->A: Loss of oligomerization. Strongly reduced
FT                   activation of Wnt signaling."
FT                   /evidence="ECO:0000269|PubMed:21189423"
FT   MUTAGEN         84
FT                   /note="R->A: Strongly reduced interaction with DIXDC1."
FT   CONFLICT        356
FT                   /note="D -> G (in Ref. 1; AAC52827)"
FT                   /evidence="ECO:0000305"
FT   HELIX           423..431
FT                   /evidence="ECO:0007829|PDB:3ML6"
FT   STRAND          435..437
FT                   /evidence="ECO:0007829|PDB:3ML6"
FT   STRAND          440..442
FT                   /evidence="ECO:0007829|PDB:3ML6"
FT   STRAND          449..454
FT                   /evidence="ECO:0007829|PDB:3ML6"
FT   HELIX           455..464
FT                   /evidence="ECO:0007829|PDB:3ML6"
FT   HELIX           472..485
FT                   /evidence="ECO:0007829|PDB:3ML6"
FT   STRAND          486..493
FT                   /evidence="ECO:0007829|PDB:3ML6"
FT   STRAND          499..505
FT                   /evidence="ECO:0007829|PDB:3ML6"
SQ   SEQUENCE   736 AA;  78861 MW;  928A527143BBBBB0 CRC64;
     MAGSSAGGGG VGETKVIYHL DEEETPYLVK IPVPAERITL GDFKSVLQRP AGAKYFFKSM
     DQDFGVVKEE ISDDNARLPC FNGRVVSWLV SSDTPQPEVA PPAHESRTEL VPPPPPLPPL
     PPERTSGIGD SRPPSFHPNV SSSHENLEPE TETESVVSLR RDRPRRRDSS EHGAGGHRPG
     GPSRLERHLA GYESSSTLMT SELESTSLGD SDEDDTMSRF SSSTEQSSAS RLLKRHRRRR
     KQRPPRMERT SSFSSVTDST MSLNIITVTL NMEKYNFLGI SIVGQSNERG DGGIYIGSIM
     KGGAVAADGR IEPGDMLLQV NDMNFENMSN DDAVRVLRDI VHKPGPIVLT VAKCWDPSPQ
     AYFTLPRNEP IQPIDPAAWV SHSAALTGAF PAYPGSSSMS TITSGSSLPD GCEGRGLSVH
     MDMASVTKAM AAPESGLEVR DRMWLKITIP NAFLGSDVVD WLYHHVEGFP ERREARKYAS
     GLLKAGLIRH TVNKITFSEQ CYYVFGDLSG GCESYLVNLS LNDNDGSSGA SDQDTLAPLP
     GATPWPLLPT FSYQYPAPHP YSPQPPPYHE LSSYTYGGGS ASSQHSEGSR SSGSTRSDGG
     AGRTGRPEER APESKSGSGS ESELSSRGGS LRRGGEPGGT GDGGPPPSRG STGAPPNLRA
     LPGLHPYGAP SGMALPYNPM MVVMMPPPPP PVSTAVQPPG APPVRDLGSV PPELTASRQS
     FHMAMGNPSE FFVDVM
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024